Organon & Co. OGN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.10B | 6.13B | 6.16B | 6.22B | 6.30B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.10B | 6.13B | 6.16B | 6.22B | 6.30B |
| Cost of Revenue | 2.83B | 2.86B | 2.85B | 2.84B | 2.79B |
| Gross Profit | 3.27B | 3.27B | 3.32B | 3.38B | 3.51B |
| SG&A Expenses | 1.71B | 1.70B | 1.72B | 1.72B | 1.75B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.89B | 4.92B | 4.93B | 4.92B | 4.95B |
| Operating Income | 1.21B | 1.21B | 1.23B | 1.29B | 1.36B |
| Income Before Tax | 503.00M | 491.00M | 537.00M | 425.00M | 702.00M |
| Income Tax Expenses | 290.00M | 282.00M | 291.00M | 238.00M | 201.00M |
| Earnings from Continuing Operations | 213.00 | 209.00 | 246.00 | 187.00 | 501.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 213.00M | 209.00M | 246.00M | 187.00M | 501.00M |
| EBIT | 1.21B | 1.21B | 1.23B | 1.29B | 1.36B |
| EBITDA | 1.55B | 1.56B | 1.60B | 1.65B | 1.70B |
| EPS Basic | 0.81 | 0.80 | 0.95 | 0.72 | 1.93 |
| Normalized Basic EPS | 1.79 | 1.77 | 1.87 | 1.95 | 2.07 |
| EPS Diluted | 0.76 | 0.77 | 0.93 | 0.71 | 1.91 |
| Normalized Diluted EPS | 1.75 | 1.75 | 1.86 | 1.94 | 2.05 |
| Average Basic Shares Outstanding | 1.05B | 1.04B | 1.04B | 1.04B | 1.04B |
| Average Diluted Shares Outstanding | 1.07B | 1.05B | 1.04B | 1.04B | 1.04B |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.34 | 0.60 |
| Payout Ratio | 9.39% | 8.61% | 8.94% | 47.06% | 31.54% |